Thermopylae Holdings Ltd.'s Form 4 filing
AbCellera Biologics Inc. (ABCL) · filed Mar 11, 2025
- Accession no.
- 0001628280-25-012154
- Filed
- Mar 11, 2025
- Trade date
- Mar 11, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $742.2K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thermopylae Holdings Ltd.CIK 0001834449 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2025 | Common Shares | PPurchaseAcquired | +343,631 | $2.16 | +$742,242.96 | 56,143,640 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.